Cardiomyopathy

The cardiac myosin inhibitor is expected to be available in the US in the second half of January 2026.

Stethoscope wrapped around heart | Image credit: New Africa – stock.adobe.com

December 19th 2025

Genetic, Inflammatory Predictors of Nondilated Left Ventricular Cardiomyopathy Progression

Hand holding nose spray | Image credit: I Viewfinder – stock.adobe.com

December 16th 2025

FDA Approves Intranasal Etripamil for Type of Arrhythmia

Man on treadmill connected to ECG electrodes. | Image credit: .shock – stock.adobe.com

November 28th 2025

Stress Echo Reveals Hidden Risks in Asymptomatic Hypertrophic Cardiomyopathy

Doctor handing pills to patient | Image credit: joyfotoliakid – stock.adobe.com

November 26th 2025

Real-World Risks of Mavacamten Use for Obstructive Hypertrophic Cardiomyopathy

CME Content

Online Article

New and Approved: FDA’s 2024 Drug Lineup

1.5 Credits / General Pharmacy

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Leveraging Managed Care to Optimize Patient Outcomes: Integrating Novel Treatments in Schizophrenia

1.5 Credits / Neurology, Psychiatry

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

Overcoming Operational and Clinical Barriers in Multiple Myeloma: Managed Care Strategies for Antibody-Based Regimens

1.5 Credits / Hematologic Cancer, Hematology, Oncology

Exploring Therapeutic Advances in Myelofibrosis and Key Considerations for Effective Management

1.5 Credits / Oncology, Hematology

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

1.5 Credits / Cardiology

Optimizing the Uptake of Long-Acting Injectables in HIV Treatment and Prevention: Considerations for Managed Care

1.5 Credits / HIV/AIDS, Infectious Disease

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

1.5 Credits / Ophthalmology/Optometry

Navigating the Advancements in Oral Therapy Options in HR+ Metastatic Breast Cancer

1.5 Credits / Breast Cancer, Oncology, Women's Health

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

1.5 Credits / Endocrinology, Diabetes & Metabolism, Gastroenterology

Managed Care Approaches and Models for Equitable Access to Innovations in Major Depressive Disorder Treatment

1.5 Credits / Psychiatry

Evaluating the Effectiveness and Value of Novel Nonhormonal Treatments in the Management of Menopause-Related Vasomotor Symptoms

1.5 Credits / Women's Health

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunization, Infectious Disease, Pulmonology

Leveraging Biologics and Immunotherapies in the Management of Food Allergies

1.5 Credits / Immunology, Allergy

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

1.5 Credits / Ophthalmology/Optometry

The Evolving Landscape of Transthyretin Amyloidosis Cardiomyopathy: New Therapies and Treatment Strategies

1.5 Credits / Cardiology, Rare Diseases

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Care Burden

1.5 Credits / Immunology

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

1.5 Credits / Gastroenterology, Immunology

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

1.5 Credits / Gastroenterology

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

1.5 Credits / Gastroenterology, Immunology

The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updates for Managed Care

1.0 Credit / Immunology, Nephrology

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

1.5 Credit / Ophthalmology/Optometry

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

1.5 Credit / Ophthalmology/Optometry

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

1.0 Credit / Pain Management/Opioids

The Expanding Therapeutic Landscape in IgA Nephropathy: A Case-Based Exploration of Optimized Patient Outcomes

1.0 Credit / Immunology, Nephrology